Teton Womens Health Center

CLIA Laboratory Citation Details

2
Total Citations
7
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 13D0926382
Address 2001 S Woodruff Ave #10, Idaho Falls, ID, 83404
City Idaho Falls
State ID
Zip Code83404
Phone208 523-2060
Lab DirectorWILLIAM DENSON

Citation History (2 surveys)

Survey - June 14, 2023

Survey Type: Standard

Survey Event ID: XBYR11

Deficiency Tags: D5209 D5417 D5805 D5807

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on a review of laboratory policies and procedures and an interview with the laboratory lead on 6/14/2023, the laboratory failed to establish a policy for training and competency. The findings include: 1. A review of laboratory policies and procedures identified that the laboratory failed to establish a policy listing requirements for train new testing personnel, steps for monitoring testing personnel competency that include the six required elements and identify when remedial training is needed. 2. An interview with the laboratory lead on 6/14/2023 at 9:55 am confirmed the above finding. 3. The laboratory reports performing 450 tests annually. D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on direct observations and an interview with the laboratory lead on 6/14/2023, the laboratory failed to discontinue the use of reagents when they had exceeded their expiration date. The findings include: 1. Direct observation in patient exam room five identified one bottle of Consult Diagnostics 10 SG urine reagent strips lot Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- URS0120162 expiration 4/2/2023 and a direct observation in the laboratory identified one bottle of Consult Diagnostics 10 SG urine reagent strips lot URS0120162 expiration 4/2/2023 that the laboratory failed to discontinue use of before they exceeded the expiration. 2. An interview with the laboratory lead on 6/14/2023 at 10: 19 am confirmed the above expired reagents. 3. The laboratory reports performing 4800 urinalysis tests annually. D5805 TEST REPORT CFR(s): 493.1291(c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on a review of patient laboratory reports and an interview with the laboratory lead on 6/14/2023, the laboratory failed to list all testing performed and their results for BD Affirm testing on patient laboratory test reports. The findings include: 1. A review of patient laboratory test reports for BD Affirm panel testing identified that the laboratory failed to list all test analytes performed and their corresponding results. 2. An interview with the laboratory lead on 6/14/2023 at 10:00 am confirmed that the above findings. 3. The laboratory reports performing 450 BD Affirm tests annually. D5807 TEST REPORT CFR(s): 493.1291(d) Pertinent "reference intervals" or "normal" values, as determined by the laboratory performing the tests, must be available to the authorized person who ordered the tests and, if applicable, the individual responsible for using the test results. This STANDARD is not met as evidenced by: Based on a review of patient laboratory test reports and an interview with the laboratory lead on 6/14/2023, the laboratory failed to include the normal values for the reported BD Affirm analytes on patient laboratory test reports. The findings include: 1. A review of patient laboratory test reports identified that the laboratory failed to include the normal values for the analytes tested in the BD Affirm panel: Candida species, Gardnerella vaginalis, Trichomonas vaginalis. 2. An interview with the laboratory lead on 6/14/23 at 10:00 am confirmed the above findings. 3. The laboratory reports performing 450 BD Affirm tests annually. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 15, 2019

Survey Type: Standard

Survey Event ID: F2HU11

Deficiency Tags: D5445 D5781 D6021

Summary:

Summary Statement of Deficiencies D5445 CONTROL PROCEDURES CFR(s): 493.1256(d)(1)(2)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- (d)(1) Perform control procedures as defined in this section unless otherwise specified in the additional specialty and subspecialty requirements at 493.1261 through 493.1278. (d)(2) For each test system, perform control procedures using the number and frequency specified by the manufacturer or established by the laboratory when they meet or exceed the requirements in paragraph (d)(3) of this section. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on a record review and an interview with the laboratory lead, the laboratory failed to perform quality control for each new lot of test kits received prior to patient testing and failed to establish an Individualized Quality Control Plan (IQCP) for the test BD Affirm VPIII microbial identification system since the last survey on September 20, 2017. Findings: 1. A review of quality control results from the BD Affirm microbial test kit revealed the laboratory failed to perform quality control on each new kit lot number received between August 18, 2018 and June 6, 2019 prior to reporting patient test results for Candida albicans, Trichomonas vaginalis, and Gardnerella vaginalis. 2. A review of the laboratory procedures revealed the laboratory failed to establish an IQCP that includes the number, type, and frequency of quality control used for each test system as specified by the manufacturers. 3. The laboratory performed approximately 105 microbial tests between August 18, 2018 and June 6, 2019. 4. An interview with the laboratory lead on July 15, 2019, at 1:20 PM, confirmed the laboratory failed to establish an IQCP and perform quality control for each new kit lot received. D5781

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access